News Agency
The Times

Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product

  • Written by PR Newswire
  • Alteogen grants exclusive rights to develop and commercialize a subcutaneous biologic product using Hybrozyme™-based hyaluronidase ALT-B4
  • Alteogen is eligible to receive up to US$365 million, including an upfront payment and development, regulatory and sales milestone payments
  • Additional royalties to be paid based on net sales following...

Read more: Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the...

Selecting Steel Plate for Industrial and Fabrication Projects

Start with the job requirements A successful fabrication project starts with material that suits the work it must perform. Choosing steel plate involves more than selecting a thickness from a stock list. Designers and procurement teams need to consider the load... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion